Caricamento...
Point-of-care testing of coagulation in patients treated with edoxaban
Edoxaban, alongside other direct oral anticoagulants (DOAC), is increasingly used for prevention of thromboembolism, including stroke. Despite DOAC therapy, however, annual stroke rate in patients with atrial fibrillation remains 1–2%. Rapid exclusion of relevant anticoagulation is necessary to guid...
Salvato in:
| Pubblicato in: | J Thromb Thrombolysis |
|---|---|
| Autori principali: | , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515947/ https://ncbi.nlm.nih.gov/pubmed/32436010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02143-2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|